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KEY POINTS
 The optimal timing of delivery for the baby is 39 weeks, avoiding the morbidity associated
with early term birth and reducing the risk of antepartum stillbirth.
 There is compelling evidence that among high-risk pregnancies and in settings where ce-
sarean rates are high (>20%), induction of labor at 37 to 40 weeks does not, as previously
thought, result in a further increased risk of cesarean delivery.
 The only advantage to planned cesarean delivery over induction of labor is the avoidance
of the morbidity associated with emergency cesarean delivery; controversy exists on the
other reported benefits.
 There is a growing number of well-conducted randomized controlled trials that provide
some support for induction of labor shortly before term for a variety of indications (hyper-
tensive disorders, gestational diabetes, suspected growth restriction, macrosomia, and
advanced maternal age).INTRODUCTION
A young, healthy primiparous woman attends your antenatal clinic requesting delivery
at 39 weeks. There is no indication for delivery before 41 weeks’ gestation. How do
you counsel her? What is the optimal timing (when), method (how), and reason
(why) for delivery at term? In this article, the authors aim to provide you with a sum-
mary of the relevant information to help you counsel this woman and help her to reach
an informed decision about her care. When should we offer delivery? What gestation
represents the optimal timing for delivery at term? As with all decisions in maternity
care, optimal timing may be different for the mother than the baby and a balance
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Walker & Thornton200weeks (37–42 weeks) may influence the risk of complications for the mother and for
the baby.
OPTIMAL DELIVERY TIMING
Baby
Antepartum risks
Risk of antepartum stillbirth Stillbirth accounts for two-thirds of perinatal deaths, and
early neonatal deaths account for 33%.1 Intrapartum causes of stillbirth account for
just 8.8% of all stillbirths. Excluding intrapartum causes, antepartum stillbirth ac-
counts for 61% of all perinatal deaths.1 Twenty-eight percent of antepartum stillbirths
are unexplained.1 Antepartum stillbirth is by far the most common cause of perinatal
death at term.2 Six percent of stillbirths are due to congenital abnormalities, and 35%
of stillbirths occur at 37 to 42 weeks (the most common gestation for stillbirths to
occur). Term, singleton, normally formed, antepartum stillbirth (ie, potentially prevent-
able stillbirths) made up one-third of all stillbirths (1039 [32%] out of 3286) in the United
Kingdom in 2013.
Choosing the correct denominator The risk of perinatal death at gestational ages near
term is often expressed as the number of all perinatal deaths at each week divided by
the total number of births. However, near term a baby cannot be stillborn once it has
been delivered. Thus, the risk of remaining undelivered at each gestational age is bet-
ter expressed as the risk per 100 babies undelivered at that time point, termed the
perinatal risk index. Although the perinatal mortality rate is lowest at 41 weeks, the
gestational age associated with the lowest cumulative risk of perinatal death is
38 weeks.2
Neonatal risks
Risk of respiratory morbidity Most elective cesarean deliveries are performed at or af-
ter 390/7 weeks’ gestation.3 The timing of this is advised because the risk of neonatal
respiratory morbidity decreases with advancing gestation until 400/7 weeks. The risk of
respiratory morbidity in infants delivered by elective cesarean at 370/7 weeks is 4-fold
higher than infants delivered at 40 weeks, 3-fold higher compared with those delivered
at 38 weeks, and 2-fold higher than those delivered at 39 weeks. The risk of devel-
oping neonatal respiratory symptoms for babies born by vaginal delivery decreases
from a probability of 0.07 at 37 weeks to 0.04 at 39 weeks and thereafter plateaus.4
Thus, induction of labor at 39 weeks is the optimal balance between the risk of respi-
ratory morbidity for the neonate and the risk of antepartum stillbirth for the fetus.
Hyperbilirubinaemia There have been reports of an association between the use of
oxytocin in labor and neonatal hyperbilirubinaemia.5 However, it is difficult to disen-
tangle possible confounding by the earlier gestational age of babies who were deliv-
ered following induction of labor. Although Cochrane reviews of high versus low doses
of oxytocin6 and early versus late use7 do not report jaundice, at least one trial showed
no effect.8 Gestational age of less than 38 weeks is a risk factor for the development of
significant hyperbilirubinaemia.9 In an observational study comparing outcomes for
low-risk singleton term newborns by gestational age, delivery at less than 38 weeks
was an independent risk factor for the development of unexplained jaundice (odds
ratio [OR]5 2.1, 95% confidence interval [CI] 1.7–2.5).10 The DAME trial, a randomized
controlled trial (RCT) of induction of labor at 37 to 38 weeks’ gestation versus expec-
tant management for suspected large-for-gestational-age babies, found higher rates
of hyperbilirubinaemia requiring phototherapy in the induction group compared with
the expectantly managed group.11
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risk factor for the development of neonatal hypoglycemia (OR 5 2.5, 95% CI
1.5–4.3).10 Perhaps unsurprisingly given the increased risk of respiratory morbidity,
jaundice, and hypoglycemia associated with delivery at 37 weeks’ gestation, the rates
of admission to neonatal intensive care are also inversely proportional to delivery
gestational age.12
Observational studies have also suggested an increased risk of neonatal encepha-
lopathy in children with cerebral palsy associated with delivery at 41 weeks or greater
versus less than 41 weeks.13
Thus, the current data suggest that 39 weeks’ gestation is the optimal gestational
age for delivery for the baby, as it avoids the morbidity associated with early term birth
and reduces the risk of antepartum stillbirth post term.
Maternal
Risk of cesarean delivery
Observational data suggest that induction of labor results in an increased risk of ce-
sarean delivery.14–16 For example, in England from 2010 to 2011, cesarean rates
were 11% among women who labored spontaneously and 23% among those who
were induced. Rates of operative vaginal delivery followed similar trends (12% and
17%, respectively).17 However, there is significant confounding by delivery indication,
as the reasons for induction (eg, postdates pregnancy, fetal growth restriction,
reduced fetal movements) are also established risk factors for operative delivery.
When observational studies choose the correct comparison group (ie, induction of la-
bor vs expectant management), studies have shown no difference in cesarean delivery
rates at term,18 irrespective of whether delivery occurs during the early or late-term
time period.
Randomized trials of induction near term provide unbiased evidence. There have
now been at least 38 such trials and at least 3 systematic reviews.19–21 These data
show that induction of labor at term is not associated with an elevated rate of ce-
sarean or instrumental delivery (Table 1). Despite the compelling evidence, this re-
mains a contentious issue among health care professionals and women. Many of
the trials included in the systematic reviews are for induction in postdate pregnan-
cies or high-risk groups (eg, hypertensive disorders) rather than low-risk women.
The ARRIVE trial, an RCT of induction of labor at 39 weeks versus expectantTable 1
Rates of cesarean delivery and instrumental delivery in prospective randomized studies and
systematic reviews of induction of labor at term
Study
Gestational
Age (y)
Cesarean
Delivery Instrumental Delivery
OR/RR 95% CI OR/RR 95% CI
Wood et al,20 2013 37–42 0.83 0.76, 0.92 1.09 0.98, 1.22
Saccone & Berghella,21 2015 39–40 1.25 0.75, 2.08 1.22 0.83, 1.81
Stock et al,18 2012 37 1.02 0.89, 1.17 0.93 0.81, 1.06
38 1.03 0.94, 1.13 0.95 0.87, 1.04
39 1.08 1.00, 1.16 0.98 0.91, 1.05
40 0.83 0.79, 0.88 0.85 0.82, 0.89
41 0.66 0.63, 0.69 0.78 0.74, 0.81
Mishanina et al,19 2014 37–41 0.87 0.82–0.92 Not applicable Not applicable
Abbreviation: RR, relative risk.
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labor is associated with a significant reduction in cesarean delivery (18% vs 22%,
RR 0.84, 95% CI 0.76 - 0.93).22
Are there other maternal risks you can mention briefly? They are discussed briefly
later but are worth mentioning here in this context, such as the risk of preeclampsia
and so forth, which increases at term, and whether or not expectant management
versus a plan to outright deliver at 39 weeks might be associated with an elevated
risk for preeclampsia, eclampsia, and so forth.
HOW SHOULD WE DELIVER?
Now that the authors have considered when to deliver at term, they explore the mode
of delivery. The choice that exists is not elective cesarean versus vaginal birth. It is
elective cesarean versus trial of vaginal birth, as the latter may or may not succeed.
A planned trial of vaginal birth is accomplished either by induction of labor or expec-
tant management (ie, waiting until the spontaneous onset of labor or until the develop-
ment of a medical problem that mandated induction). First, the authors explore the
risks of induction of labor itself (not the method used).
Induction of Labor
The authors have already examined induction of labor versus expectant management
in terms of risk of cesarean delivery, but induction of labor is associated with other po-
tential complications for themother and her fetus. Risks to themother during induction
include failed induction, cord prolapse during amniotomy due to a poorly engaged
presenting part, maternal pain, placental abruption due to rapid decompression of
the uterine cavity at amniotomy, and uterine hyperstimulation. Fortunately, these com-
plications are uncommon.
Cord prolapse
Umbilical cord prolapse complicates 1.25 to 2.1 per 1000 deliveries.23,24 In one retro-
spective study of 57 cases over a 10-year period, cord prolapse occurred with amniot-
omy in 42% of cases.23 However, does amniotomy increase the risk of cord prolapse?
A retrospective case control study of 37 patients of intrapartum umbilical cord pro-
lapse and 74 matched control patients with intact membranes found that the use of
amniotomy in patients who had a cord prolapse was similar between groups.25 A
larger retrospective case control study in which 80 patients of umbilical cord prolapse
were matched with 800 controls found that amniotomy was not associated with um-
bilical cord prolapse; in contrast, there was a 9-fold increased risk of umbilical cord
prolapse associated with spontaneous rupture of membranes.26 Umbilical cord pro-
lapse is associated with significant morbidity to both the mother and the fetus, as
emergent cesarean delivery is indicated as soon as possible after detection.
Uterine hyperstimulation
Uterine hyperstimulation is generally defined asmore than 5 contractions in 10minutes
or contractions lasting more than 2 minutes. This complication arises in approximately
1% to 5% of cases whereby pharmacologic agents are used to induce labor27 and
may also occur in spontaneous labor. It may occur with or without fetal heart rate
changes. During uterine contractions, blood flow to the intervillous space (where ox-
ygen exchange between the mother and the fetus occurs) is interrupted.28 Between
contractions, in the relaxation phase, blood flow, and, thus, oxygen exchange, is
restored. If the interval between contractions is reduced, or if the duration of the con-
tractions increase, then a critical point may be reached whereby fetal hypoxemia
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with significant fetal oxygen desaturation and nonreassuring fetal heart rate changes.
Maternal pain
There is evidence that induced labor is more painful than spontaneous labor. UK data
on analgesia in labor reveal that women who deliver vaginally who have an induced
labor are more than twice as likely to request epidural anesthesia as women in spon-
taneous labor (21% vs 8%17). One small study (n 5 61) by Capogna and colleagues29
found that the minimum effective analgesic dosage of sufentanil (a synthetic opioid)
given via an epidural for women with an induced labor was 1.3 times greater than in
women with a spontaneous onset of labor (P 5 .0014). In the authors’ RCT of 195 pri-
miparous women aged 35 years or older comparing labor induction at 39 weeks of
gestation versus expectant management, they observed a higher rate of epidural us-
age in women in the induction arm (35%) than the expectant management arm (29%),
though this failed to reach statistical significance (P 5 .11).30
Labor duration
It is difficult to perform meaningful comparisons of the duration of labor between
induced and spontaneous labor even in randomized trials. Women undergoing induc-
tion of labor have a clear time of onset (eg, the time of insertion of prostaglandin, a
balloon catheter, or amniotomy). In contrast, the time of onset for women in sponta-
neous labor is difficult to define. In a large retrospective observational study of
low-risk women comparing approximately 10,000 women who labored spontaneously
with 1000 women who underwent labor induction for no apparent medical indication,
induction was not associated with a prolonged labor. However, induction was associ-
ated with a longer admission-to-delivery interval and the maternal total length of stay
was 0.34 days longer with induction compared with spontaneous labor (P.0001).14
Findings were similar in a retrospective study of 2681 low-risk multiparous women,
whereby women who were induced had a significantly shorter labor than those who
labored spontaneously (99 minutes vs 161 minutes, P.001).31
MODE OF DELIVERY
Cesarean Delivery
To avoid these complications of induction of labor, should we offer elective cesarean
delivery? In 2013, the National Institute for Health and Clinical Excellence introduced
new guidance on maternal requests for cesarean delivery stating that “if after discus-
sion and offer of support, a vaginal birth is still not an acceptable option, offer a
planned [cesarean section] CS.”32 Rates of cesarean delivery performed primarily
for maternal request vary by country. In the United Kingdom in 2001, 7% of all cesar-
eans were elective for maternal request.33 Although there is a paucity of data in the
literature to know whether these rates have recently increased, overall cesarean deliv-
ery rates in the United Kingdom have remained stable (2012 25.5%, 2015 26.5%). It is
imperative that the comparison groups are carefully examined when evaluating obser-
vational data on vaginal delivery versus planned cesarean. The best comparison is
planned cesarean delivery versus planned vaginal delivery (ie, an intention-to-treat
approach). Some women in the planned vaginal delivery group will deliver by un-
planned cesarean delivery.
Benefits to cesarean delivery
Avoidance of perineal trauma An elective cesarean delivery avoids the risk of perineal
trauma associated with vaginal delivery. Perineal trauma of varying degrees occurs in
85% of women who give birth vaginally in the United Kingdom. Obstetric anal
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primiparous women and 0.8% of multiparous women following a vaginal delivery,
though its true incidence is likely to be 11.0%.34 One randomized study with clear un-
biased data (the Twin Birth study) had no cases (0%) of obstetric anal sphincter injury
in the planned cesarean delivery group and 4 cases (0.3%) in the planned vaginal de-
livery group.35
Reduction in urinary and fecal incontinence and pelvic organ prolapse There is less
certainty when it comes to the matter of long-term urogynecologic outcomes,
including urinary and fecal incontinence and pelvic organ prolapse.34 In the case of
stress urinary incontinence, any protection offered by a planned cesarean delivery
is reduced by advancing age, multiple cesarean deliveries (no protection if 3), cesar-
ean deliveries performed in labor and future vaginal births. Even women with all deliv-
eries by cesarean delivery are not immune to developing these complications. Vaginal
delivery may lead to an impairment in anal function in 2 ways: obstetric anal sphincter
injury and pudendal neuropathy. This latter mechanism may explain why, although
planned cesarean delivery has been shown to be protective against obstetric anal
sphincter injury,36 it may not be completely protective against anal dysfunction. In a
questionnaire study of 1336 women aged 40 to 60 years, there was no association be-
tween vaginal delivery (as opposed to cesarean delivery) and self-reporting of symp-
toms of anal dysfunction.37
The Term Breech Trial found lower rates of urinary incontinence at 3 months post
partum among women in the planned cesarean delivery group (36 of 798 women in
the cesarean group [4.5%] and 58 out of 797 women in the planned vaginal delivery
[7.3%]; relative risk [RR] 0.62; 95% CI 0.41–0.93),38 but at 2 years post partum, the
rates of urinary incontinence were not significantly different between groups (81 of
457 women in the cesarean group [17.8%] and 100 of 460 women in the planned
vaginal delivery [21.8%]; RR 0.81; 95% CI 0.63–1.06).39 The Term Breech Trial found
no significant difference in self-reported rates of fecal or flatus incontinence between
groups at 3 months or 2 years.38,39 Thus, there is insufficient evidence to recommend
a planned cesarean delivery to reduce the risk of stress urinary incontinence.
A large observational study looking at the risk factors for pelvic organ prolapse
found that parity was the most significant independent risk factor and the risk in-
creases with each successive baby (Fig. 1).40
Although parity has a significant role in the risk of pelvic organ prolapse, is planned
cesarean delivery protective? A large questionnaire study of more than 4000 women
measured self-reported pelvic organ prolapse and found there was no significantFig. 1. Relationship between risk of pelvic organ prolapse and parity.
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had delivered by cesarean. However, the risk was increased in parous women who
had delivered vaginally. When comparing parous women who had delivered by cesar-
ean versus parous women who had delivered vaginally, the adjusted OR (aOR) was
1.82 (CI 1.04–3.19). When comparing parous women who had delivered vaginally
versus nulliparous women, the aOR was 3.21 (CI 1.96–5.26). The findings were similar
in another large questionnaire study of 2000 women, whereby the OR increased with
increasing numbers of vaginal births (cesarean only OR 1.6 [0.4–6.4], 1 vaginal birth
OR 2.8 [1.1–7.2], 2 vaginal births OR 4.1 [1.8–9.5], 3 or more vaginal births OR 5.3
[2.3–12.5]). From the observational data, there seems to be an association between
vaginal delivery and self-reporting of pelvic organ prolapse.
Risks of cesarean delivery
Cesarean delivery constitutes major abdominal surgery and carries both short- and
long-term risks, summarized in Table 2.
Lilford and colleagues41 explored the risks of maternal mortality associated with
vaginal delivery, elective cesarean, and emergency cesarean excluding women with
medical or life-threatening antenatal complications. They found that the risk of
maternal mortality for cesarean versus vaginal delivery was 5:1 and emergency cesar-
ean versus elective cesarean was 1.5:1. The main reason vaginal delivery is safer than
cesarean delivery is not the comparison between the first cesarean delivery and first
vaginal birth but the exponential increase in risks associated with subsequent cesar-
ean deliveries summarized with the phrase “the first cut is not the deepest.”
Placenta previa and the morbidly adherent placenta The maternal and neonatal
morbidity and mortality associated with placenta previa and placenta accrete are
considerable. Rates of both conditions are increasing because of the increasing ce-
sarean delivery rate and increasing maternal age. This increase is because
the placenta is less likely to migrate upward with the development of the lower uterine
segment if there is a scar in it. Placenta previa is associated with an increased risk of
major obstetric hemorrhage (1000 mL blood loss; OR 13.1, 95% CI 7.47–23.0),42
massive obstetric hemorrhage (1500 mL blood loss) (21%),43 need for bloodTable 2
Summary of short- and longer-term risks of cesarean delivery versus vaginal delivery
Studies Suggest
May be Reduced
by Vaginal Delivery
Studies Give
Conflicting Evidence
Studies Suggest No
Difference
Studies Suggest
May be Reduced by
Cesarean Delivery
 Length of
maternal
hospital stay
 Peripartum
hysterectomy due
to postpartum
hemorrhage
 Cardiac arrest
 Maternal death
 Deep vein
thrombosis
 Blood transfusion
 Infection
 Hysterectomy
 Anesthetic
complications
 Perineal and abdominal
pain at 4 mo post
partum
 Injury to urinary tract
 Injury to cervix
 Iatrogenic surgical
injury
 Pulmonary embolism
 Wound infection
 Intraoperative trauma
 Uterine trauma
 Assisted ventilation or
intubation
 Acute renal failure
 Perineal and
abdominal pain
during birth and
at 3 d post partum
 Vaginal trauma
 Early postpartum
hemorrhage
 Obstetric shock
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accreta are profound. Women with the placenta accrete spectrum are at high risk
for an indicated preterm delivery, which most commonly occurs by planned cesarean
hysterectomy, and are at risk for major or massive obstetric hemorrhage, urologic
(bladder, ureteral) injury, and other complications. Risks of placenta accrete spectrum
increase exponentially with the number of prior cesarean deliveries and are highest
among women with multiple prior cesarean deliveries and placenta previa.
Uterine scar dehiscence or rupture Uterine rupture is associated with maternal and
perinatal morbidity and mortality. A landmark observational study by Landon and col-
leagues44 examined the maternal and perinatal outcomes of vaginal birth after cesar-
ean delivery versus elective repeat cesarean delivery and showed that the risk of
uterine rupture associated with vaginal birth after one cesarean delivery was 0.7%.
Twelve babies whose mothers had a trial of vaginal birth developed hypoxic ischemic
encephalopathy (0.08%); of those 12 cases, 7 were associated with uterine rupture.
Thirty-five women (0.2%) had a hysterectomy (5 cases were performed for irreparable
rupture), and 3 women (0.02%) died (of which no cases were associated with uterine
rupture). In a large observational study of 159 cases of uterine rupture in the United
Kingdom from 2009 to 10, 2 women (1.3%) died and 18 perinatal deaths associated
with uterine rupture occurred (12.0%).45
Antepartum stillbirth in subsequent pregnancy There is an association between
cesarean delivery in the first pregnancy and unexplained antepartum stillbirth in the
second pregnancy. Smith and colleagues46 found that the risk of unexplained antepar-
tum stillbirth at 39 weeks’ or greater gestation was 1.1 per 1000 women who had had a
previous cesarean delivery versus 0.5 per 1000 women in those who had delivered
vaginally. The investigators postulate this association may be due to impaired uterine
vasculature due to previous surgery, abnormal placentation, and subsequent utero-
placental dysfunction.WHY SHOULD WE DELIVER?
Specific Indications for Delivery at Term
Reduced fetal movements and stillbirth prevention
Raised awareness of reduced fetal movements is one of the 4 key elements of the
Saving Babies Lives care bundle implemented across the United Kingdom to try to
reduce antepartum stillbirths.47 In the confidential inquiry into term antepartum still-
births, in just less than half of a random sample of stillbirths reviewed by an expert
panel women reported decreased fetal movement.48 In a third of those stillbirths, a
major failure of care was identified; in the remaining cases, there were also lesser de-
ficiencies in care identified. In a retrospective cohort study in New Zealand comparing
fetal movement data from women with late stillbirth with women with ongoing preg-
nancies at the same gestational age as the stillbirth had occurred, decreased fetal
movement was associated with an increased risk of late stillbirth (aOR 2.37, 95% CI
1.29–4.35).49 The results of this study must be interpreted with caution, as the study
is limited by recall bias. Although the association between decreased and antepartum
stillbirth is clear, complaints of reduced fetal movements are common and subjective;
it is uncertain how to differentiate pathologic decreased movements from a more tran-
sient situation. One Norwegian quality-improvement study implemented a policy of
(1) providing written information about reduced fetal movements, (2) an invitation to
monitor fetal movement, and (3) a guideline for health professionals on the manage-
ment of reduced fetal movement across 14 hospitals.50 They found a reduction in
Delivery at Term 207the stillbirth rate among women with reduced fetal movement during the intervention
(4.2% versus 2.4%; OR 0.51 95%, CI 0.32–0.81) and an overall reduction in the still-
birth rate in the whole study population 3.0 per 1000 versus 2.0 per 1000 (OR 0.67,
95% CI 0.48–0.93). What is remarkable was that this was achieved with a reduction
in the number of inductions of labor and no change in the rate of cesarean deliveries.
Hypertensive disorders
Hypertensive disorders in pregnancy are common and cause considerable maternal
and fetal morbidity and mortality. The Hypertension and Preeclampsia Intervention
Trial At Term (HYPITAT), an RCT of induction of labor within 48 hours versus expectant
management for women with pregnancy-induced hypertension or mild preeclampsia
between 3610 and 4110 weeks found that induction of labor was associated with a
reduction in the primary outcome (a composite of poor maternal outcomes).51 These
investigators concluded that induction of labor should be advised at 37 weeks’ gesta-
tion for women with pregnancy-induced hypertension or mild preeclampsia. However,
it is notable that the only individual component of the composite that was statistically
significantly increased in the control group versus the induction group was the occur-
rence of severe hypertension and subsequent need for antihypertensive medication,
though the study was likely underpowered to detect less common individual
outcomes, such as eclampsia.
Gestational diabetes
The association between pregestational diabetes and stillbirth is widely known.52 The
perinatal mortality rate for womenwith preexisting diabetes (type 1 or 2) is 32 per 1000,
compared with 9 per 1000 in the general population. The guidelines from the United
Kingdom National Institute for Health and Care Excellence and the American College
of Obstetricians and Gynecologists both recommend that pregnant women with pre-
gestational diabetes be offered medically indicated delivery from 38 weeks.53 Notably,
however, in a retrospective audit of 25 cases of stillbirth in women with type I diabetes
mellitus in Denmark, the median gestational age at the time the stillbirth was diag-
nosed was 35 weeks.54
Advanced maternal age
The average age at childbirth in industrialized nations has been steadily increasing for
about 30 years.55 Between 1996 and 2006, births to women older than 35 years have
increased from 12% to 20% of all births. In the same year, 5.6% of live births were to
nulliparous women older than 35 years.56 Women older than 35 years are at a higher
risk of antepartum and intrapartum stillbirths and neonatal deaths, hypertensive dis-
ease, gestational diabetes, placenta previa, and placental abruption.1,55,57 Further,
they are at an increased risk of preterm labor and of bearing macrosomic (>3999 g)
or low-birth-weight infants (<2500 g). The women themselves typically think that their
age puts their infant at increased risk.57 Unsurprisingly, they have higher rates of ob-
stetric intervention.
The cesarean delivery rate for nulliparous women older than 35 years in the United
Kingdom is 38% and 50% in women older than 40 years.57 In nulliparous women, the
relationship between maternal age and delivery by emergency cesarean is linear.58
Stillbirth is an important risk to mitigate among women 35 years old or older
because older women are relatively less likely to have future pregnancies. Induction
at or before termmay be beneficial because 38 weeks is the gestational age of delivery
associated with the lowest cumulative risk of perinatal death.2 Nulliparous women
have a higher risk of stillbirth than multiparous women for all maternal age groups.59,60
It is recognized by obstetricians that older women reach the 41- to 42-week stillbirth
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ages59; but as discussed, stillbirth risk is only one risk to consider.
Some obstetricians induce older pregnant women at the due date (40 weeks)
(39% women aged 40–44 years, 58% women aged more than 45 years); but of those
who do not, one-third are reluctant to offer it for fear of increasing the risk of cesarean
despite thinking it will improve perinatal outcomes.30 The authors conducted an RCT
of 619 primiparous women 35 years old or older. Women were randomly assigned to
labor induction at 3910 to 3916 weeks’ gestation or to expectant management. The
primary outcome was cesarean delivery. In an intention-to-treat analysis, there were
no significant between-group differences in the percentage of women who underwent
a cesarean delivery (98 of 304 women in the induction group [32%] and 103 of 314
women in the expectant-management group [33%]; RR 0.99; 95% CI 0.87–1.14) or
in the percentage of women who had a vaginal delivery with the use of forceps or vac-
uum (115 of 304 women [38%] and 104 of 314 women [33%], respectively; RR 1.30;
95% CI 0.96–1.77). There were no maternal or infant deaths and no significant
between-group differences in the women’s experience of childbirth or in the frequency
of adverse maternal or neonatal outcomes.
In conclusion, the optimal timing of delivery for the baby is 39 weeks, avoiding the
morbidity associated with early term birth and reducing the risk of antepartum stillbirth.
There is compelling evidence that among high-risk pregnancies and in settings
where cesarean rates are high (>20%), induction of labor at 37 to 40 weeks does
not, as previously thought, result in a further increased risk of cesarean delivery.
The only advantage to planned cesarean delivery over induction of labor is the avoid-
ance of the morbidity associated with emergency cesarean delivery; controversy ex-
ists on the other reported benefits. There is a growing number of well-conducted RCTs
that provide some support for induction of labor shortly before term for a variety of in-
dications (hypertensive disorders, gestational diabetes, suspected growth restriction,
macrosomia, and advanced maternal age).
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